June 3, 2022
Abstract Background People with HIV (PWH) have subclinical coronary artery disease (CAD) despite low traditional atherosclerotic cardiovascular disease (ASCVD) risk scores. Coronary plaque in PWH presents […]
June 3, 2022
Abstract Background Limited data are available regarding asymptomatic COVID-19 among people with HIV (PWH). Data on a representative subset of PWH enrolled in REPRIEVE, a global clinical trial […]
May 2, 2022
By Heather Boerner Read the full article here.
May 2, 2022
By Barbara Jungwirth and Myles Helfand Read the full article here.
May 2, 2022
By Liz Highleyman Read the full article here.
March 7, 2022
Abstract Background We sought to explore multinational differences in functional status by Global Burden of Disease (GBD) regions in the REPRIEVE cohort. Methods REPRIEVE is a […]
March 3, 2022
Abstract Background Among ART-treated people with HIV (PWH), persistent systemic immune activation contributes to atherogenesis, cardiovascular disease (CVD) events, and mortality. Factors associated with key immune […]
December 13, 2021
By Caitlyn Stulpin Read the full article here.
December 13, 2021
Rates are similar to the general population but vary across geographic regions. Read the full article here.
June 3, 2022
Abstract Background People with HIV (PWH) have subclinical coronary artery disease (CAD) despite low traditional atherosclerotic cardiovascular disease (ASCVD) risk scores. Coronary plaque in PWH presents […]
June 3, 2022
Abstract Background Limited data are available regarding asymptomatic COVID-19 among people with HIV (PWH). Data on a representative subset of PWH enrolled in REPRIEVE, a global clinical trial […]
May 2, 2022
By Heather Boerner Read the full article here.
May 2, 2022
By Barbara Jungwirth and Myles Helfand Read the full article here.
May 2, 2022
By Liz Highleyman Read the full article here.
March 7, 2022
Abstract Background We sought to explore multinational differences in functional status by Global Burden of Disease (GBD) regions in the REPRIEVE cohort. Methods REPRIEVE is a […]
March 3, 2022
Abstract Background Among ART-treated people with HIV (PWH), persistent systemic immune activation contributes to atherogenesis, cardiovascular disease (CVD) events, and mortality. Factors associated with key immune […]
December 13, 2021
By Caitlyn Stulpin Read the full article here.
December 13, 2021
Rates are similar to the general population but vary across geographic regions. Read the full article here.